Literature DB >> 17331981

Two endoplasmic reticulum-associated degradation (ERAD) systems for the novel variant of the mutant dysferlin: ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II).

Eriko Fujita1, Yoriko Kouroku, Atsushi Isoai, Hiromichi Kumagai, Akifumi Misutani, Chie Matsuda, Yukiko K Hayashi, Takashi Momoi.   

Abstract

Dysferlin is a type-II transmembrane protein and the causative gene of limb girdle muscular dystrophy type 2B and Miyoshi myopathy (LGMD2B/MM), in which specific loss of dysferlin labeling has been frequently observed. Recently, a novel mutant (L1341P) dysferlin has been shown to aggregate in the muscle of the patient. Little is known about the relationship between degradation of dysferlin and pathogenesis of LGMD2B/MM. Here, we examined the degradation of normal and mutant (L1341P) dysferlin. Wild-type (wt) dysferlin mainly localized to the ER/Golgi, associated with retrotranslocon, Sec61alpha, and VCP(p97), and was degraded by endoplasmic reticulum (ER)-associated degradation system (ERAD) composed of ubiquitin/proteasome. In contrast, mutant dysferlin spontaneously aggregated in the ER and induced eukaryotic translation initiation factor 2alpha (eIF2alpha) phosphorylation and LC3 conversion, a key step for autophagosome formation, and finally, ER stress cell death. Unlike proteasome inhibitor, E64d/pepstatin A, inhibitors of lysosomal proteases did not stimulate the accumulation of the wt-dysferlin, but stimulated aggregation of mutant dysferlin in the ER. Furthermore, deficiency of Atg5 and dephosphorylation of eIF2alpha, key molecules for LC3 conversion, also stimulated the mutant dysferlin aggregation in the ER. Rapamycin, which induces eIF2alpha phosphorylation-mediated LC3 conversion, inhibited mutant dysferlin aggregation in the ER. Thus, mutant dysferlin aggregates in the ER-stimulated autophagosome formation to engulf them via activation of ER stress-eIF2alpha phosphorylation pathway. We propose two ERAD models for dysferlin degradation, ubiquitin/proteasome ERAD(I) and autophagy/lysosome ERAD(II). Mutant dysferlin aggregates on the ER are degraded by the autophagy/lysosome ERAD(II), as an alternative to ERAD(I), when retrotranslocon/ERAD(I) system is impaired by these mutant aggregates.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17331981     DOI: 10.1093/hmg/ddm002

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  149 in total

1.  Survival and death of endoplasmic-reticulum-stressed cells: Role of autophagy.

Authors:  Yan Cheng; Jin-Ming Yang
Journal:  World J Biol Chem       Date:  2011-10-26

Review 2.  The delicate balance between secreted protein folding and endoplasmic reticulum-associated degradation in human physiology.

Authors:  Christopher J Guerriero; Jeffrey L Brodsky
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

3.  ER stress: Autophagy induction, inhibition and selection.

Authors:  Harun-Or Rashid; Raj Kumar Yadav; Hyung-Ryong Kim; Han-Jung Chae
Journal:  Autophagy       Date:  2015-11-02       Impact factor: 16.016

4.  OS9 Protein Interacts with Na-K-2Cl Co-transporter (NKCC2) and Targets Its Immature Form for the Endoplasmic Reticulum-associated Degradation Pathway.

Authors:  Elie Seaayfan; Nadia Defontaine; Sylvie Demaretz; Nancy Zaarour; Kamel Laghmani
Journal:  J Biol Chem       Date:  2015-12-31       Impact factor: 5.157

5.  Quality control autophagy degrades soluble ERAD-resistant conformers of the misfolded membrane protein GnRHR.

Authors:  Scott A Houck; Hong Yu Ren; Victoria J Madden; Jacob N Bonner; Michael P Conlin; Jo Ann Janovick; P Michael Conn; Douglas M Cyr
Journal:  Mol Cell       Date:  2014-03-27       Impact factor: 17.970

Review 6.  Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease.

Authors:  Arthur Kaser; Richard S Blumberg
Journal:  Semin Immunol       Date:  2009-02-23       Impact factor: 11.130

Review 7.  Crosstalk Between Endoplasmic Reticulum Stress, Oxidative Stress, and Autophagy: Potential Therapeutic Targets for Acute CNS Injuries.

Authors:  Venkata Prasuja Nakka; Phanithi Prakash-Babu; Raghu Vemuganti
Journal:  Mol Neurobiol       Date:  2014-12-09       Impact factor: 5.590

8.  ER-to-lysosome-associated degradation of proteasome-resistant ATZ polymers occurs via receptor-mediated vesicular transport.

Authors:  Ilaria Fregno; Elisa Fasana; Timothy J Bergmann; Andrea Raimondi; Marisa Loi; Tatiana Soldà; Carmela Galli; Rocco D'Antuono; Diego Morone; Alberto Danieli; Paolo Paganetti; Eelco van Anken; Maurizio Molinari
Journal:  EMBO J       Date:  2018-08-03       Impact factor: 11.598

9.  Mpl traffics to the cell surface through conventional and unconventional routes.

Authors:  Cédric Cleyrat; Anza Darehshouri; Mara P Steinkamp; Mathias Vilaine; Daniela Boassa; Mark H Ellisman; Sylvie Hermouet; Bridget S Wilson
Journal:  Traffic       Date:  2014-07-18       Impact factor: 6.215

10.  Limited proteolysis as a tool to probe the tertiary conformation of dysferlin and structural consequences of patient missense variant L344P.

Authors:  Natalie Woolger; Adam Bournazos; Reece A Sophocleous; Frances J Evesson; Angela Lek; Birgit Driemer; R Bryan Sutton; Sandra T Cooper
Journal:  J Biol Chem       Date:  2017-09-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.